129 related articles for article (PubMed ID: 8069589)
1. Enhanced antitumour effects using a combination of two antibodies conjugated to different drugs.
Rowland AJ; McKenzie IF; Pietersz GA
J Drug Target; 1994; 2(2):113-21. PubMed ID: 8069589
[TBL] [Abstract][Full Text] [Related]
2. Selective enhancement of antitumor activity of N-acetyl melphalan upon conjugation to monoclonal antibodies.
Smyth MJ; Pietersz GA; McKenzie IF
Cancer Res; 1987 Jan; 47(1):62-9. PubMed ID: 3791221
[TBL] [Abstract][Full Text] [Related]
3. Tumour eradication with high-dose idarubicin-anti-Ly-2.1 with murine tumour necrosis factor-alpha in mice.
Pietersz GA; Bogdanovski M; Li W
Immunol Cell Biol; 1997 Jun; 75(3):253-8. PubMed ID: 9243290
[TBL] [Abstract][Full Text] [Related]
4. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
Pietersz GA; Smyth MJ; McKenzie IF
Cancer Res; 1988 Feb; 48(4):926-31. PubMed ID: 3422182
[TBL] [Abstract][Full Text] [Related]
5. Increased antitumor effect of immunoconjugates and tumor necrosis factor in vivo.
Smyth MJ; Pietersz GA; McKenzie IF
Cancer Res; 1988 Jul; 48(13):3607-12. PubMed ID: 3259905
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of human tumor necrosis factor-alpha (hTNFalpha) chemically conjugated to monoclonal antibody.
Pietersz GA; Toohey B; McKenzie IF
J Drug Target; 1998; 5(2):109-20. PubMed ID: 9588867
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model.
Smyth MJ; Bogdanovski M; McKenzie IF; Pietersz GA
Cancer Res; 1991 Jan; 51(1):310-7. PubMed ID: 1988093
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
9. Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates.
Rowland AJ; Pietersz GA; McKenzie IF
Cancer Immunol Immunother; 1993 Aug; 37(3):195-202. PubMed ID: 7687521
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of 2'-deoxy-5-fluorouridine conjugates against a murine thymoma and colon carcinoma xenografts.
Krauer KG; McKenzie IF; Pietersz GA
Cancer Res; 1992 Jan; 52(1):132-7. PubMed ID: 1530766
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
[TBL] [Abstract][Full Text] [Related]
12. Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates.
Smyth MJ; Pietersz GA; McKenzie IF
J Natl Cancer Inst; 1987 Dec; 79(6):1367-73. PubMed ID: 2891866
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
Kuin A; Aalders M; Lamfers M; van Zuidam DJ; Essers M; Beijnen JH; Smets LA
Br J Cancer; 1999 Feb; 79(5-6):793-801. PubMed ID: 10070871
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of T-2 toxin-conjugated monoclonal antibody to murine thymoma.
Ohtani K; Murakami H; Shibuya O; Kawamura O; Ohi K; Chiba J; Otokawa M; Ueno Y
Jpn J Exp Med; 1990 Apr; 60(2):57-65. PubMed ID: 2384978
[TBL] [Abstract][Full Text] [Related]
15. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
16. Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates.
Smyth MJ; Foster HM; Andrew SM; Teh JG; Krauer K; McKenzie IF; Pietersz GA
Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():167-79. PubMed ID: 8349300
[TBL] [Abstract][Full Text] [Related]
17. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
18. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
Fishwild DM; Aberle S; Bernhard SL; Kung AH
Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534
[TBL] [Abstract][Full Text] [Related]
20. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
